These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24998427)

  • 1. Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols.
    Ryckewaert L; Sacconnay L; Carrupt PA; Nurisso A; Simões-Pires C
    Toxicol Lett; 2014 Sep; 229(2):374-80. PubMed ID: 24998427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.
    Therrien E; Larouche G; Nguyen N; Rahil J; Lemieux AM; Li Z; Fournel M; Yan TP; Landry AJ; Lefebvre S; Wang JJ; MacBeth K; Heise C; Nguyen A; Besterman JM; Déziel R; Wahhab A
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2514-8. PubMed ID: 25971769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
    Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
    Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
    Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G
    Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor.
    Park JB
    PLoS One; 2016; 11(3):e0150392. PubMed ID: 26986569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-step synthesis of novel, bioactive derivatives of the ubiquitous cofactor nicotinamide adenine dinucleotide (NAD).
    Pesnot T; Kempter J; Schemies J; Pergolizzi G; Uciechowska U; Rumpf T; Sippl W; Jung M; Wagner GK
    J Med Chem; 2011 May; 54(10):3492-9. PubMed ID: 21528845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
    Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
    Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
    Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
    J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.
    Huhtiniemi T; Salo HS; Suuronen T; Poso A; Salminen A; Leppänen J; Jarho E; Lahtela-Kakkonen M
    J Med Chem; 2011 Oct; 54(19):6456-68. PubMed ID: 21895016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
    Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
    J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.
    Rotili D; Carafa V; Tarantino D; Botta G; Nebbioso A; Altucci L; Mai A
    Bioorg Med Chem; 2011 Jun; 19(12):3659-68. PubMed ID: 21306905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
    Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in inhibitors of sirtuin1/2: an update and perspective.
    Zhou Z; Ma T; Zhu Q; Xu Y; Zha X
    Future Med Chem; 2018 Apr; 10(8):907-934. PubMed ID: 29642711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry.
    Loharch S; Chhabra S; Kumar A; Swarup S; Parkesh R
    Bioorg Chem; 2021 May; 110():104768. PubMed ID: 33676042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Javamide-I-O-methyl ester increases p53 acetylation and induces cell death via activating caspase 3/7 in monocytic THP-1 cells.
    Park JB
    Phytomedicine; 2016 Dec; 23(13):1647-1652. PubMed ID: 27823629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring N
    Li R; Yan L; Sun X; Zheng W
    Bioorg Med Chem; 2020 Apr; 28(7):115356. PubMed ID: 32067892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Modifications of Benzimidazoles via Multi-Step Synthesis and Their Impact on Sirtuin-Inhibitory Activity.
    Yoon YK; Choon TS
    Arch Pharm (Weinheim); 2016 Jan; 349(1):1-8. PubMed ID: 26616218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening approach of sirtuin inhibitors results in two new scaffolds.
    Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M
    Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors.
    Zheng YC; Wang LZ; Zhao LJ; Zhao LJ; Zhan QN; Ma JL; Zhang B; Wang MM; Wang ZR; Li JF; Liu Y; Chen ZS; Shen DD; Liu XQ; Ren M; Lv WL; Zhao W; Duan YC; Liu HM
    Cell Physiol Biochem; 2016; 38(1):185-93. PubMed ID: 26784898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.
    Rotili D; Tarantino D; Nebbioso A; Paolini C; Huidobro C; Lara E; Mellini P; Lenoci A; Pezzi R; Botta G; Lahtela-Kakkonen M; Poso A; Steinkühler C; Gallinari P; De Maria R; Fraga M; Esteller M; Altucci L; Mai A
    J Med Chem; 2012 Dec; 55(24):10937-47. PubMed ID: 23189967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.